AVIENCE
AVIENCE financials
- Market cap
- ₹192 Cr
- Sector
- Healthcare
- Calls analysed
- 1
AVIENCE H2 & FY26
What went well
- FY26 consolidated revenue increased to ₹52.51 crore, up 16.06% from FY25.
- EBITDA margin improved to 28.45% in FY26 from 25.35% in FY25, a 310 bps expansion.
- Profit after tax grew by 23.31% to ₹8.75 crore in FY26.
What to watch
- Working capital requirement for ₹100 crore revenue could be ₹35-40 crore, requiring external funding.
- Entering an expansion phase will lead to increased expenses, potentially offsetting margin improvements in the short term.
Guidance record · Q4 FY26
updates from the last two tracked quarters 9 tracked 0 delivered 0 missed 9 open- Revenue Growth open said Q4 FY26 Promised: at least 60% in FY27 Q4 FY26: We are planning for revenue growth of at least 60% in FY27 and believe growth may be higher, subject to execution.
All 9 tracked — see the targets, revisions and supporting evidence.
Open the guidance ledgerQuarterly results
| Line item | Q4 FY25 | Q2 FY26 | Q4 FY26 |
|---|---|---|---|
| Revenue | 24 | 27 | 26 |
| EBITDA | 7 | 7 | 8 |
| Net profit | 4 | 5 | 4 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −18.7% YTD
YTD: ₹414.95 on 25 Jun 2026 → ₹337.45. High ₹414.95 (25 Jun 2026), low ₹222.85 (17 Jul 2026).
How the price took the results
close before → close after
- Q4 FY26
- +3.4%
- 24 Jul
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Balance sheet
| Year ending | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr |
| Reserves | ₹1 Cr | ₹1 Cr | ₹3 Cr | ₹19 Cr | ₹27 Cr |
| Borrowings | ₹2 Cr | ₹3 Cr | ₹15 Cr | ₹22 Cr | ₹29 Cr |
| Other liabilities | ₹1 Cr | ₹3 Cr | ₹13 Cr | ₹12 Cr | ₹18 Cr |
| Total liabilities | ₹6 Cr | ₹10 Cr | ₹35 Cr | ₹56 Cr | ₹78 Cr |
| Fixed assets | ₹1 Cr | ₹3 Cr | ₹10 Cr | ₹13 Cr | ₹16 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹5 Cr | ₹13 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹5 Cr | ₹8 Cr | ₹24 Cr | ₹39 Cr | ₹49 Cr |
| Total assets | ₹6 Cr | ₹10 Cr | ₹35 Cr | ₹56 Cr | ₹78 Cr |
How to read this
As filed on each reporting date, including interim balance sheets. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
- Promoters
- 64.6%
- FIIs
- 3.1%
- DIIs
- 9.1%
- Public
- 23.3%
Who is on the register
Named in the Jun 2026 filing
Every holder of AVIENCE above SEBI's 1% disclosure line.
| Holder | Stake |
|---|---|
| Dharam Deo Choudhary | 37.17% |
| Ram Nagina Choudhary | 11.71% |
| Deepa Choudhary | 7.99% |
| Janardan Pal | 7.66% |
| Maniramka Compound 365 Llp | 3.65% |
| Sanshi Fund-I AIF | 2.64% |
| Meru Investment Fund Pcc-Cell 1 FPI fund | 2.20% |
| Fortune Hands Growth Fund- Fortune Hands Growth Fund Scheme | 1.75% |
| Asnani Stock Broker Private Limited | 1.50% |
| Huf | 0.67% |
| NBFCs registered with RBI NBFC / DFI | 0.09% |
| Arti Pal | 0.02% |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse AVIENCE
Guides on how to read this kind of business and the numbers that matter.